| Product Name | MF | CAS | Details |
|---|
| lorvotuzumab | 339306-30-8 | Details |
| Bivatuzumab | 214559-60-1 | Details |
| BCPA | C22H22Cl2N2O2 | 547731-67-9 | Details |
| BCAT-IN-4 | C19H14N2O4S | 406190-85-0 | Details |
| FC-116 | C21H20FNO4 | 2417298-29-2 | Details |
| SARS-CoV-2-IN-39 | C14H8ClF4NO3 | 2882823-03-0 | Details |
| TIM-3-IN-2 | C25H23N3O6 | 1113126-49-0 | Details |
| PI3Kδ-IN-16 | C22H26N6O2 | 2766437-35-6 | Details |
| B-Raf IN 16 | C20H19N5O3S | 2304746-24-3 | Details |
| Antimalarial agent 30 | C18H11F3N2 | 1597425-64-3 | Details |
| MC4033 | C16H13N3O3 | 28532-21-0 | Details |
| Lingdolinurad | C17H12BrN3O2 | 2088176-96-7 | Details |
| Ipamorelin 2 Pivalic acid | C38H49N9O5 | Details |
| LW3 | C17H12F3N3O | 2803367-68-0 | Details |
| JHU 75528 | C23H21Cl2N5O2 | 947696-17-5 | Details |
| Anti-inflammatory agent 51 | C22H22N6O6S | 2911610-03-0 | Details |
| Aprocitentan | C16H14Br2N6O4S | 1103522-45-7 | Details |
| a-MSH, amide Acetate(581-05-5 free base) | C77H109N21O19S | Details |
| RN-1665 | C20H24F5N3O3S2 | 1803003-65-7 | Details |
| Tubulin polymerization-IN-55 | C22H24N2O4 | 2942396-29-2 | Details |
| AP-C2 | C18H16N4S | 682793-07-3 | Details |
| 17β-HSD10-IN-1 | C16H13ClN4O3S | 2316765-78-1 | Details |
| KM02894 | C7H9N3OS2 | 116850-74-9 | Details |
| KSK94 | C25H26N4O | 2566716-07-0 | Details |
| CpCDPK1/TgCDPK1-IN-1 | C18H17N5 | 1092788-23-2 | Details |
| Tubulin inhibitor 32 | C18H19N3O3 | 2923531-39-7 | Details |
| AMPK activator 12 | C23H24BrNO2 | 431920-24-0 | Details |
| (1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid | C16H23N3O2.C4H6O6 | 2919211-45-1 | Details |
| Estrogen receptor antagonist 8 | 2889370-92-5 | Details |
| MMP-9-IN-6 | C25H19NO2 | 2241964-36-1 | Details |
| Z16078526 | C18H17N3O4S | 852222-94-7 | Details |
| AST 7062601 | C18H15N3O4S | 675197-89-4 | Details |
| 1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- | C23H20N2S | 138801-72-6 | Details |
| KSK68 | C23H28N2O2 | 2566715-91-9 | Details |
| AKE-72 | C30H29F3N6O | 2566525-18-4 | Details |
| Anti-inflammatory agent 49 | C21H22N8O3S | 851471-44-8 | Details |
| TIE-2/VEGFR-2 kinase-IN-5 | C21H13F6N5O2 | 1014407-83-0 | Details |
| Nrf2 activator-3 | C23H18F3N3O2 | 2766570-23-2 | Details |
| XPW1 | C36H39ClFN7O2 | 2700286-66-2 | Details |
| EGFR/ErbB-2 inhibitor-1 | C23H15ClFN3OS2 | 1135150-79-6 | Details |
| QST4 | C16H13ClN4O2S2 | 2991427-35-9 | Details |
| Trontinemab | 2568868-35-7 | Details |
| MoTPS1-IN-1 | C23H27F3N2O4 | 2991072-02-5 | Details |
| h-NTPDase-IN-3 | C16H10N4S | 2939933-10-3 | Details |
| LCC-12 FA | 3029253-76-4 | Details |
| P-gb-IN-1 | C30H28N2O6 | 2632874-49-6 | Details |
| Nurr1 agonist 2 | C18H14O3S | 742058-34-0 | Details |
| (S)-OSMI 3 | C32H35N3O9S2 | 2411972-78-4 | Details |
| 20-HETE Intermediate 15 | C23H36O4 | 1286736-37-5 | Details |
| EBOV-IN-1 | C34H43N3O5 | 1335113-30-8 | Details |
| Safingol hydrochloride | C18H39NO2. HCl | 139755-79-6 | Details |
| Tenilapine | 82650-83-7 | Details |
| TNF/IFNγ-IN-1 | C20H23N3O6 | 876013-29-5 | Details |
| OPC18750 HCl | C20H22N2O4.ClH | 145364-90-5 | Details |
| Ogremorphin | C21H17N3OS | 352563-21-4 | Details |
| NSC 122393 | C20 H8 Br4 O5 | 73654-97-4 | Details |
| BIIB 722 Mesylate | C19H23F3N6O5S | 261505-81-1 | Details |
| (Z)-Tenilapine | C17H16N4S2 | 82650-82-6 | Details |
| 3,3'-Selenobisalanine | 61216-56-6 | Details |
| SQLE-IN-1 | C24H21F2N5O2S | 1019169-83-5 | Details |
| ADS032 | C22H29NO4S | 2757333-37-0 | Details |
| Phosphatase-IN-1 | C16H16Cl2FNO2 | 2889356-55-0 | Details |
| SARS-CoV-2 3CLpro-IN-16 | C17H14N2OS | 352659-40-6 | Details |
| IRG1-IN-1 | C18H15FO4 | 2407652-42-8 | Details |
| Enpp-1-IN-16 | C23H32N4O4 | 2289739-47-3 | Details |
| JG-2016 | C18H21ClN4O3 | 2887480-87-5 | Details |
| IR820-PTX | C99H112N4O21S2.Na | 2250419-19-1 | Details |
| DJ4 | C19H16N4OS | 1681020-24-5 | Details |
| PLpro/RBD-IN-1 | C13H10N4O | 1282451-83-5 | Details |
| SARS-CoV-2-IN-38 | 2882823-27-8 | Details |
| EGFR-IN-87 | C28H33N7O2 | 1835666-87-9 | Details |
| S5A1 | C27H33N3O4.ClH | 2055882-51-2 | Details |
| LFHP-1c | C55H64N6O4 | 2102347-47-5 | Details |
| LSD1-IN-30 | C15H14N2O3 | 1289575-45-6 | Details |
| CCG-13514 | C25H25BrN2O2 | 423741-32-6 | Details |
| KSK67 | C22H27N3O2 | 2566715-93-1 | Details |
| AC-099 hydrochloride | C9H9Cl2F3N4 | 849335-07-5 | Details |
| 1-N-Methyl-4-mercaptohistidine disulfide | 73491-33-5 | Details |
| IDH2R140Q-IN-2 | C21H18F6N6O | 2749568-16-7 | Details |
| MY-1076 | C29H33NO9 | 3008262-76-5 | Details |
| Cbl-b-IN-5 | C17H17N5OS | 2368835-59-8 | Details |
| DHX9-IN-2 | C18H16ClN3O3S2 | 2973395-71-8 | Details |
| Fenclozine Maleate | C45H47ClN2O12 | 76823-82-0 | Details |
| IMMH 010 maleate | C36H36BrClN2O9 | 2541982-47-0 | Details |
| Zharp2-1 | C19H18N3O2PS | 2772600-18-5 | Details |
| LSD1-IN-27 | C24H25N3 | 2904571-94-2 | Details |
| D4R agonist-1 | C19H22N4S | 2826198-44-9 | Details |
| Tubulin polymerization-IN-43 | C17H13F4N3O | 2773345-90-5 | Details |
| Topoisomerase II inhibitor 14 | C15H11Cl2N5 | 305343-00-4 | Details |
| Aneratrigine hydrochloride | C19H20ClF2N5O2S2.ClH | 2097163-75-0 | Details |
| PAC1R antagonist 1 | C17H17ClN6O2 | 2305204-24-2 | Details |
| VU534 | C21H22FN3O3S2 | 923509-20-0 | Details |
| Usenamine A | C18H17NO6 | 1428417-60-0 | Details |
| A09-003 | C23H26N4O | 2911646-14-3 | Details |
| Antiviral agent 34 | C29H33N3O2S | 945152-88-5 | Details |
| ALK-IN-26 | C24H23NO3S | 2447607-85-2 | Details |
| h-NTPDase-IN-2 | C19H16N4S | 2939933-03-4 | Details |
| A2B receptor antagonist 2 hydrochloride | C12H15N5.ClH | 724-70-9 | Details |
| TNF-α-IN-9 | C17H14O4 | 2054199-25-4 | Details |
| HA5 | C15H10O5 | 2378406-17-6 | Details |
| Product Total： Product Page： | ||||
| 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 | ||||